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Background: Atrial Fibrillation is the most common arrhythmia encountered following cardiac surgery. The most
commonly administered drug used in treatment and prophylaxis is amiodarone which has several toxic effects on
major organ functions. There are few clinical data concerning prevention of toxic effects and there is no routinely
suggested agent. The aim of this study is to document the cytotoxic effects of amiodarone on cell culture media
and compare the cytoprotective effects of commonly used antioxidant agents.
Methods: L929 mouse fibroblast cell line was cultured and 100,000 cells/well-plate were obtained. First group of
cells were treated with increasing concentrations of amiodarone (20 to 180 μM) alone. Second and third group of
cells were incubated with one-fold equimolar dose of vitamin C and N-acetyl cysteine prior to amiodarone
exposure. The viability of cells were measured by MTT assay and the cytoprotective effect of each agent was
compared.
Results: The cytotoxicity of amiodarone was significant with concentrations of 100 μM and more. The viabilities of
both vitamin C and N-acetyl cysteine treated cells were higher compared to untreated cells.
Conclusions: Vitamin C and N-acetyl cysteine are commonly used in the clinical setting for different purposes in
context of their known antioxidant actions. Their role in prevention of amiodarone induced cytotoxicity is not fully
documented. The study fully demonstrates the cytoprotective role of both agents in amiodarone induced
cytotoxicity on cell culture media; more pronounced with vitamin C in some concentrations. The findings may be
projectile for further clinical studies.
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Innumerous studies have been published enclosing
treatment and prophylaxis of postoperative atrial fibril-
lation (AF). Amiodarone is a type 3 anti-arrhythmic
agent frequently used for medical cardioversion with
varying protocols [1]. It has potential serious side
effects in a wide spectrum including photosensitivity,
pulmonary toxicity, polyneuropathy, gastrointestinal
upset, bradycardia, torsades de pointes (rare), hepatic
toxicity, thyroid dysfunction and ocular complications
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reproduction in any medium, provided the orCurrently, there are no clinical agents available for
prevention of amiodarone induced toxicity. The aim of
this study is to underline the toxic effects of amiodarone
in cell culture media and propose potential antioxidant
agents for clinical use in terms of preventing amiodar-
one induced toxicity.
Methods
L929 mouse fibroblastic cell line was plated in 96-well
culture plates (Greiner Bio-One, Germany) at an initial
density of 100,000 cells/well and incubated in Dulbec-
co's Modified Eagle Medium/Ham’s F12 (DMEM/F12)
(Biochrom AG, Germany) supplemented with 10% fetal
bovine serum (FBS) (Biochrom AG, Germany). Follow-
ing 24 hours of incubation period, the culture medium
was removed. The untreated cells were considered asl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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150 mg/3 ml, Sanofi-Synthalebo, İstanbul, Turkey) was
prepared in nine different concentrations (20 μM, 40 μM,
60 μM, 80 μM, 100 μM, 120 μM, 140 μM, 160 μM, 180
μM). To obtain the studied concentrations, amiodarone
was dissolved in the cell culture media. In the first group,
the cells were treated with amiodarone alone with the
mentioned concentrations. Simultaneously, fresh medium
containing one-fold the equimolar dose of amiodarone
concentrations of vitamin C (Vitabiol-CW,500 mg/5 ml,
İbrahim Etem Ulugay İlaç Sanayi Türk A.Ş, İstanbul Tur-
key) and N-acetyl cysteine (NAC) (AsistW, 100 mg/ml,
Hüsnü Arsan İlaçları A.Ş, İstanbul, Turkey) were prepared.
In the second and third groups, in order to study the po-
tential antioxidant effects, cells were preincubated with
vitamin-C and NAC for two hours, and then amiodarone
was added. After 24 hours of incubation, cell viabilities of
the three groups were assessed by the MTT assay and
compared with non-pretreated cells. Cell viability was
expressed as the relative formazan formation in treated
samples as compared to control cells [(A570 treated cells/
A570 control cells) x 100%].
Determination of cell line
L929, a murine aneuploid fibrosarcoma cell line was
employed in this study, because it is an established cell
line allowing reproducibility of the results, and cells
multiply rapidly with an unlimited life span. It is used
commonly for multiple purposes including biocompati-
bility and cytotoxicity tests [5,6].
Determination of amiodarone concentrations
The concentrations used in cell culture was based on tis-
sue concentration studies. In a survey of 122 patients
chronically treated with amiodarone treatment, serum
concentrations were measured as 0.4-3.3 (mean 1,7) mg/
l, which corresponds to 0.58-4.81 (mean 2.47) μM. Con-
centrations in myocardial tissue was approximately 30
times the serum concentration (mean 74.1 μM), whereas
up to 100 times (247 μM) in various organs [7]. In end
stage heart failure, pharmacodynamics differ. Serum
concentrations were measured as 0.68 μg/ml which
corresponds to 1 μM. Amiodarone concentrations in
myocardial tissue was approximately 15 times the serum
concentration (15 μM), whereas 150 times (150 μM) in
epicardial fat [8]. Similar concentrations used in this study
were also used in other cell culture studies made with
amiodarone[9].
MTT assay
MTT assay is a standardized procedure defining via-
bility. This colorimetric method assesses the ability
of viable cells to form MTT (3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) formazan bythe mitochondrial enzyme succinate dehydrogenase.
It was originally defined by Carmaichael et al. to as-
sess cytotoxicity [10].
To assess viability, at the end of the designed incuba-
tion period, the culture medium was replaced with 200
μl medium containing 0.5 mg/ml MTT and plates were
incubated for 3 hours at 37°C. The medium was then
removed and replaced with 200 μl of 0.04 M HCl/iso-
propanol which solubilizes the converted purple dye in
culture plates. The absorbance was measured on a spec-
trophotometer microplate reader (μQuantTM, BiotekW
Instruments Inc, USA) at a wavelength of 570 nm. Each
experiment was repeated 6 times seperately.
Statistical analysis
Statistical analyses were performed using SPSS software
for Windows (version 17.0, Statistical Package for the
Social Sciences Inc, Chicago, IL, USA). The viability of
cells in different amiodarone doses were compared using
repeated measures variance analysis. To compare viabil-
ity in each concentration according to treatment groups,
Kruskal Wallis test was used. In cases of significant dif-
ference “bonferoni adjusted Mann–Whitney u test” was
used to explore the more efficient group.
Results
When cytotoxicity of amiodarone in different doses was
examined, upto 80 μM concentration, decrease in
viability was not significant (p< 0.0001). The cytotoxic
effects appeared with concentrations of 100 μM and
more (p< 0.01). In these concentrations both vitamin C
and NAC had cytoprotective effects and lead to
increases in viability (p< 0.016) (Table 1). In concentra-
tions of 100, 140 and 180 μM vitamin C and NAC had
equal protective effects, whereas in concentrations of
120 and 160 μM, vitamin C was more efficient
(p< 0.016).
Discussion
Atrial fibrillation is the most commonly encountered
rhythm disorder following cardiac surgery. Amiodarone
is a very effective agent used in treatment and prophy-
laxis of postoperative AF [2,11-13]. The risk of toxicity
increases with increasing plasma concentrations. Due to
its high liposolubility, it accumulates in adipose tissue
and highly perfused organs such as lungs, liver and
spleen. This tendency also contributes to its toxic effects
besides from cellular mechanisms of toxicity [14].
Free radical formation, direct cytotoxicity, develop-
ment of lysosomal phospholipidosis and membrane
destabilization are the documented possible cellular
mechanisms of toxicity, but it is known that the pre-
dominant molecular mechanism of amiodarone induced
cell death is the trigger caused by oxidative damage [9].
Table 1 The mean cell viabilities (%) after treatment with amiodorane alone and with antioxidant agents
Cell viability % (Mean± SD)
Concentration Amiodarone Amiodarone+ Vitamin Ca Amiodarone +NACa p*
20 μM 117.10 ± 50.75 131.31± 36.62 133.86 ± 38.91 0.884
40 μM 130.49 ± 48.70 122.12± 24.27 91.83 ± 41.86 0.166
60 μM 97.73 ± 48.08 108.25± 16.85 133.65 ± 28.12 0.172
80 μM 81.39 ± 64.45 122.00± 19.94 120.34 ± 52.70 0.414
100 μM 59.41 ± 16.43 128.43± 30.94 108.74 ± 39.04 0.011
120 μM 26.66 ± 7.40 116.63± 23.81 74.93 ± 26.31 0.001
140 μM 19.63 ± 6.81 88.11 ± 29.38 80.33 ± 43.47 0.003
160 μM 16.92 ± 6.46 111.55± 24.02 70.18 ± 23.15 0.001
180 μM 14.91 ± 4.32 68.52 ± 25.39 48.58 ± 12.21 0.002
a Vitamin C and NAC were added at one-fold equimolar dose of amiodarone concentrations.
*Kruskal-Wallis test.
NAC: N-acetyl cysteine.
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increased production of reactive oxygen species or
decreased antioxidant capacity of cells, of which former
is the mechanism in case of amiodarone induced
cytotoxicity. Since it is not possible to prevent the devel-
opment of oxidative stress itself, it would be rational to
increase the cellular levels of antioxidants, which is the
hypothesis for eveluating the use of antioxidant agents
to prevent amiodarone induced cytotoxicity in this
study.
To date, there are few data concerning prevention of
amiodarone induced cytotoxicity. In some cell culture
and experimental animal studies antioxidants, particu-
larly vitamin E was employed and was found to be
effective in increasing viability following exposure to
toxic doses of amiodarone. Golli-Bennour et al. very
clearly demonstrated the cytoprotective role of vitamin
E on human cell culture lines [9]. Boldt et. al and Card
JW et. al reported attenuation of amiodarone induced
pulmonary fibrosis by vitamin E in experimental animal
models [15,16]. Agoston et al. studied the antioxidant ef-
fect of dietary vitamin E on rat hepatocytes concurrent
with amiodarone administration and showed reduction
of lysosomal phospholipidosis [17]. Those studies are
valuable, since they demonstrate the possible effective-
ness of antioxidants for prevention of amiodarone
toxicity. But to our knowledge very few studies with vita-
min C and NAC were carried out in order to prevent
amiodarone induced cytotoxicity.
Vitamin C mediates its antioxidant action possibly via
scavenging reactive oxygen and nitrogen species includ-
ing free radicals such as hydroxyl radicals, superoxide
anion, nitrogen dioxide and aqueous radicals. It also acts
on nonradical species such as ozone, hypochlorus acid,
singlet oxygen, nitroxide, peroxynitrite and nitrosating
species. Morover, vitamin C is capable of regenerating
small molecule antioxidants such as α-tocopherol, gluta-
thione, urate and β-karotene from their respectiveradical species [18,19]. At the cellular level, vitamin C
prevents the unwanted effects of reactive oxygen species
directly by causing an increase in cellular antioxidant en-
zyme activities and indirectly by reducing oxidized form
of vitamin E and glutathione [19]. It is obvious that
vitamin-C counteracts on multiple levels of cellular oxi-
dative stress, which we think is the key feature in
prevention of amiodarone toxicity.
N-acetyl cysteine has a similar mechanism of antioxidant
action which is mediated either directly by scavenging
reactive oxygen species or indirectly by production of gluta-
thione [20]. The cysteine component of NAC combines
with glutamate and glycine, the precursors in the produc-
tion of glutathione, in which cysteine is the rate limiting
step. Glutathione itself is the most generic antioxidant in
the body [21]. Lee et al. demonstrated the preventive role
of NAC against contrast induced nephrotoxicity measured
by MTT analysis in a similarly designed study on human
embryonic kidney cells [20]. We also believe that, NAC
prevents amiodarone induced cytotoxicity via glutathione
pathway, but molecular analysis should be made for
certainity.
When clinical side of the unknown equation of amio-
darone induced cytotoxicity is explored, the additive
effect of inflammation and oxidative stress which play
role in development of arrhythmias should also be con-
sidered. Particularly inflammatory response associated
with cardiopulmonary bypass is a critical cornerstone
following cardiac surgery. Although not fully documen-
ted, clinical use of antioxidants may also have favorable
effects in this clinical setting. Rodrigo et al. reviewed use
of antioxidants for prevention of AF and suggested use
of vitamin E and vitamin C hypothesizing that their use
not only would minimize the risk of post-cardiac surgery
AF, but also increase its treatment success [22]. Carnes
et al. reported antioxidant role of vitamin C and docu-
mented decreased risk of postoperative AF in patients
given prophylactic preoperative and postoperative
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the effects of vitamin C on recurrence of electrically car-
dioverted persistent AF and found decreased incidence
with vitamin C [24]. In none of the studies, their role in
amiodarone treatment was noted. Different from those
findings, our study documented the preventive role of
vitamin C against amiodarone cytotoxicity in cell culture
media.
When NAC is considered in clinical use, Ozaydin et al.
reported NAC to have favorable effects in prevention of
postoperative AF [25]. They did not use NAC together
with amiodarone. Serviddio et al. studied liver toxicity
during amiodarone administration in an animal experi-
ment and documented that NAC completely prevented
mitochondrial respiratory chain dysfunction and mem-
brane phospholipid damage caused by amiodarone [26].
In cell culture, we also found that NAC prevents amiodar-
one induced cytotoxicity.
Our findings are valuable in terms of defining cytotoxic
effects of amiodarone which occur only in moderate to
high doses. In lower doses (80 μM or less), the toxicity is
not noted with amiodarone in our study.
The viabilities were measured to be more than 100% in
some measurements. There are several explanations for
that. The control group is the untreated cells whose spec-
trophotometric measurements were made after the first
24 hours of incubation period. But for amiodarone alone
and amiodarone with antioxidant treated cells, the mea-
surements were made following a second 24 hours of
incubation period. The cytotoxic effects of amiodarone
began above 100 μM concentration. Moreover, the cul-
ture media in which the agents were dissolved, possibly
served as a suitable medium for proliferation during the
second 24 hours period in lower concentrations.
Conclusions
The findings of the study demonstrate that vitamin C
and N-acetyl cysteine are thought to be effective in
terms of decreasing cellular cytotoxicity of amiodarone.
The ease and rapidness of using cell culture media for
cytoxicity tests are worth noting. Non-clinical, laboratory
based studies usually are incapable of answering clinical
questions and direct projections are hardly made. But,
since the agents used in this study for prevention of
cytotoxicity are commonly administered, almost naive
agents used for multiple purposes in the routine clinical
setting, the findings may be useful for further clinical
studies.
Limitations
L929 is a very frequently used and reliable cell line
employed in cytotoxicity tests, so it was the choice of cell
line in our study. But human cell lines could also be usedfor more reliable analysis. Especially, human hepatic and
renal cell lines could provide a better understanding of
antioxidant behavior of vitamin-C and NAC in terms of
prevention of amiodarone induced cytotoxicity, and easier
future projections could be made. A similar study with
vitamin E was performed by Golli-Bennour on human cell
culture lines, and protective effects were demonstrated
[9]. But L929 can be considered as a standard cell line
employed in cytotoxicity tests, so the results are consid-
ered as reliable.
The results could also be supported with further ana-
lyses like measurement of lipid peroxidation products
which shows the oxidative status of amiodarone treated
cells.Abbreviations
AF: Atrial fibrillation; NAC: N-acetyl cysteine; MTT: (3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide).
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